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ARTICLE
Developing an intervention to facilitate family
communication about inherited genetic conditions,
and training genetic counsellors in its delivery
The Socio-Psychological Research in Genomics (SPRinG) Collaboration: Ivan Eisler1, Matthew Ellison2,
Frances Flinter3, Jo Grey4, Suzanne Hutchison1, Carole Jackson5, Louise Longworth6, Rhona MacLeod7,
Marion McAllister8, Alison Metcalfe*,5, Trevor Murrells5, Christine Patch3, Stuart Pritchard9, Glenn Robert5,
Emma Rowland5 and Fiona Ulph10
Many families experience difﬁculty in talking about an inherited genetic condition that affects one or more of them. There have
now been a number of studies identifying the issues in detail, however few have developed interventions to assist families.
The SPRinG collaborative have used the UK Medical Research Council’s guidance on Developing and Evaluating Complex
Interventions, to work with families and genetic counsellors (GCs) to co-design a psycho-educational intervention to facilitate
family communication and promote better coping and adaptation to living with an inherited genetic condition for parents and
their children (o18 years). The intervention is modelled on multi-family discussion groups (MFDGs) used in psychiatric settings.
The MFDG was developed and tested over three phases. First focus groups with parents, young people, children and health
professionals discussed whether MFDG was acceptable and proposed a suitable design. Using evidence and focus group data,
the intervention and a training manual were developed and three GCs were trained in its delivery. Finally, a prototype MFDG was
led by a family therapist and co-facilitated by the three GCs. Data analysis showed that families attending the focus groups and
intervention thought MFDG highly beneﬁcial, and the pilot sessions had a signiﬁcant impact on their family’ functioning. We also
demonstrated that it is possible to train GCs to deliver the MFDG intervention. Further studies are now required to test the
feasibility of undertaking a deﬁnitive randomised controlled trial to evaluate its effectiveness in improving family outcomes
before implementing into genetic counselling practice.
European Journal of Human Genetics (2016) 24, 794–802; doi:10.1038/ejhg.2015.215; published online 7 October 2015
INTRODUCTION
Families affected by Inherited Genetic Conditions (IGCs) face
challenges in living with the condition and its risks in the present as
well as attempting to manage the risk implications for future
generations through reproductive decision making.1–4 One of the
biggest issues for parents is deciding when and how to talk to their
children about the genetic condition, in an age and developmentally
appropriate manner while promoting psychological well-being.3–8
Most health professionals advocate that parents should begin to talk
to their children about the IGC as soon as possible, gradually
providing more information suited to their children’s age and
development.6 This assists children’s maintenance of trust in their
parents and affords them the opportunity to cope with and adapt to
knowing about the IGC as they grow up, rather than ﬁnding out about
the IGC in a dramatic and shocking way, which happens in many
families.3,9 Delayed or non-disclosure of genetic risk information
reduces family cohesion,10,11 which may result in family conﬂicts3,4
and/or poor emotional and psychological well-being in families.3,9,12
Many parents want more support from health professionals about
managing the IGC within the family and advice about talking to their
children;6 however few have appropriate opportunities. Genetic
counsellors (GC) are uncertain about how involved they should be
in helping families to communicate risk information.13 Current
practice focuses predominantly on the support of the individual
affected or at risk, often to the exclusion of the wider family
unit.6,13,14
In response to these ﬁndings we aimed to design an intervention
that will assist parents and children in talking about and coping with
the IGC affecting their family. Following a literature review and a
discussion with senior family therapists, GC leaders, patient group
representatives and researchers, we agreed that a multi-family discus-
sion group (MFDG) intervention might be the most suitable model.
MFDG interventions provide a safe context in which families can learn
from and support each other, reduce their sense of isolation and
stigma, and help to improve communication within families as well as
between families and clinical staff.10 MFDG interventions are also
potentially more cost-effective11,15–18 than one-to-one family therapy.
In MFDG settings, facilitators help families to share their experi-
ences of living with their condition and ﬁnd new and more effective
ways of managing it. They have been successfully applied to a variety
1South London and Maudsley NHS Foundation Trust, London, UK; 2Huntington’s Disease Youth Organisation, London, UK; 3Guy’s and St Thomas’ NHS Foundation Trust,
London, UK; 4Association for Multiple Endocrine Neoplasia Disorders (AMEND), Tunbridge Wells, UK; 5Kings College London, London, UK; 6Brunel University London, Middlesex,
UK; 7Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; 8Cardiff University, Cardiff, UK; 9Genetic Alliance UK, London, UK; 10University of
Manchester, Manchester, UK
*Correspondence: Professor A Metcalfe, Florence Nightingale Faculty of Nursing and Midwifery, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, London
SE1 8WA, UK. Tel: +44 (0)207 848 3828; Fax: +44 (0)207 848 3506; E-mail: Alison.Metcalfe@kcl.ac.uk
Received 7 May 2015; revised 29 June 2015; accepted 5 July 2015; published online 7 October 2015
European Journal of Human Genetics (2016) 24, 794–802
& 2016 Macmillan Publishers Limited All rights reserved 1018-4813/16
www.nature.com/ejhg
of mental,15,18–21 chronic health,22–24 familial cancer,17 and beha-
vioural problems.25 MFDGs are based on the premise that families
affected by the condition are better suited to understand and make
suggestions to other families about how to cope and adapt,10 and the
MFDG provides an environment to facilitate this constructive process.
Our research questions were ‘Are Multi-Family Discussion Groups
a suitable intervention for facilitating family communication about an
IGC?’ and ‘Is it possible to train GCs to deliver the intervention?’ The
three study aims were (i) To ascertain whether a MFDG was a suitable
approach, and acceptable to both families (parents, children, and
young people) affected by IGCs and to GCs. (ii) To work with families
and GCs to co-design the intervention to meet the needs of those
receiving and delivering it and (iii) To train GCs in the intervention’s
delivery.
MATERIALS AND METHODS
Following ethical approval by the NHS Riverside Ethics Committee, London;
reference: 13/LO/0236, three methodological phases were undertaken to
develop the intervention and pilot it with a group of families (see Figure 1).
Phase 1—focus groups for co-designing the MFDG
Families, parents, children (5–12 years), and young people (13–18 years),
affected by or at risk from an IGC were recruited via a regional genetics unit in
the United Kingdom and advertisements on charity web-pages, social media,
and newsletters. Interested families contacted the researchers and were provided
with more study information. Potential participants were screened over the
telephone to ascertain whether they had spoken to their children about the IGC
in their family. If sufﬁcient communication had taken place, that is, the genetic
condition had been talked about with the children, then the family was invited
to participate. All family members were sent information packs including
recruitment letters, and consent/assent forms that were age and developmen-
tally appropriate. Where communication had not taken place parents were
invited to take part in an alternative focus group that did not include children
or young people. GCs were recruited to the same focus groups by an email
containing a recruitment pack.
Seven focus groups26–29 were conducted with families affected or at risk from
a range of IGCs and health professionals between November and December
2013 (see Figure 1). To stimulate ideas and discussions the research team
presented the MFDG concept to participants10,15 and asked families to
comment and reﬂect on its potential use in the focus groups. Focus group A
was divided into three concurrent focus groups: (i) parents, (ii) children, and
(iii) young people with three GCs allocated to each group. The focus groups
lasted between 45 and 90min according to the participants’ age/development
stage. Child-centred methodologies were used with children and young people
to support verbal communication.30–32 Families and GCs attending focus group
A were invited back to participate in focus group B, to validate the ﬁndings
from the original focus group (A) and to discuss the expected outcomes of the
intervention and how these might be measured.
Families who had not yet spoken to their children and two GCs attended one
focus group (C), which lasted 90min and parents discussed both the design
and the possible measurable outcomes of the intervention.
All focus groups were audio-recorded using encrypted digital Dictaphones
and transcribed verbatim. Observational notes taken contemporaneously by the
focus group observer and reﬂections made by the group leaders and facilitators
were typed. Data were analysed using thematic analysis.33 Transcripts were
imported into ATLAS Ti 6.2.28 for data management.34 Transcripts were read
and re-read allowing the researchers (ER, CJ, and AM) to become familiar with
the data and preliminary codes were noted.35 Codes were developed both
inductively as they emerged from the data and deductively,35 drawing on
knowledge and experience from previous research. Initial codes were discussed
by two researchers (ER and CJ) and a code list and a code book were produced
to create consistency in the coding process.36 Transcripts were coded by one
researcher (ER), re-coded by a second (CJ), and reviewed by a third (AM). This
data analysis procedure was followed for all interviews and focus groups in the
three phases of work.
Phase 2: Adaptation of the MFDG intervention and training of GCs
Two family therapists (IE and SH) and the research team used focus group
ﬁndings (phase 1) to inform the adaptation of an MFDG for use with families
affected or at risk of IGCs. With the intervention adapted, one family therapist
(SH) and the study PI (AM) developed a training manual, which included
family therapy concepts, techniques, explanations, examples of MFDG, and
references to key texts. The training manual informed and guided the training
of three GCs in MFDG therapy over a 6-month period.
The MFDG focused on four areas, which we had previously identiﬁed as
causing families the most difﬁculty in talking about and coping with the IGC3
and which re-emerged in the above focus groups. The four areas foci were (i)
setting the context and exploring families’ experiences and knowledge of the
IGC; (ii) the family’s relationship with the IGC and how it affects their
relationships with each other; (iii) coping with the emotions caused by the IGC
and understanding each other; and (iv) recognising family members’ strengths,
building self-esteem, and focusing on how lessons learned can be used in the
future. Group exercises and activities aimed at developing knowledge, skills,
and conﬁdence in relation to the four overarching areas were used with
different stratiﬁcations of family members, parents, and children in their own
peer groups, the family group or the whole group.
GC training involved four formal training sessions, role play, use of audio-
visual materials and discussions. Training sessions were supported by the
observation of MFDG’s conducted with families affected by eating disorders,
role plays with GC peers and the delivery of a small scale, 1 day mock MFDG
conducted with families who attended phase 1 focus groups. The GC’s
experiences of training were captured via three multi-perspective interviews37
that were conducted by GR before, during, and after the training had taken
place. Interviews were transcribed and imported into ATLAS Ti 6.2.28 for data
management.34,38 GC experiences of the MFDG training are reported
elsewhere.39
Phase 3—Piloting the intervention
Proceeding from the intervention’s design and training of the GCs, families
affected by or at risk from an IGC were recruited to attend a full MFDG
programme, delivered by the trained GCs. Participants were recruited via a
regional genetics unit, a specialist colorectal cancer unit, and advertisements on
charity web-pages. Interested participants contacted the research team and were
provided with verbal information and screened as in phase 1. Eligible families
were sent information and consent/assent packs. Parents were given the option
of inviting other individuals who were important in their family, for example,
grandparents and parental siblings.
Activities and discussions were designed by SH and AM with guidance from
IE to encourage family discussions around communication and functioning in
relation to the IGC. The MFDG was observed by CJ who took contempora-
neous ﬁeld notes and AM recorded reﬂections in a research diary.
The purpose of the pilot MFDG was to ascertain whether the intervention
was acceptable to families and if participants were willing and able to complete
a battery of outcome measures, which will be used in a future randomised
controlled trial (RCT). All participants were given an age appropriate booklet
containing the validated family functioning and quality of life outcome
measures which are being analysed and will be reported elsewhere once
follow-up is complete. Qualitative outcome measures, feedback, evaluation data
and observational notes of the research team were inputted into Atlas Ti 6.2.28
for data analysis.
RESULTS
We did not collect demographic information from participants but
they varied in their socio-economic and educational backgrounds.
Most participants but not all were white British or white Irish.
Phase 1—Focus groups
Eleven families affected or at risk from IGCs and nine GCs
participated in the focus groups (see Table 1). Seven families and
nine GCs attended focus group A. Five participants, two parents, two
children, and one young person, did not return to attend focus B due
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to ill health. Four families (ﬁve parents) and two GCs attended focus
group C. Two main themes emerged that informed intervention
design.
Theme 1: Clarifying the need for an intervention. Parents affected by
or at risk from IGCs said that they faced challenges in disclosing
genetic risk information to their children. Parents particularly
perceived a deﬁciency of guidance and advice from health profes-
sionals in supporting them to talk to their children, which often led
them to feel isolated and vulnerable:
“There’s no-one preparing us for [this], you’ve just got to muddle
on...” (Philip (Throughout this paper all names cited, except for the
research team, are pseudonyms to protect the identity of partici-
pants.), Father of a Daughter affected by Vascular Ehlers Danlos
Syndrome).
Parents were anxious that they did not have the right words, the
knowledge or the appropriate skills to explain genetic risk information
appropriately. Parents were worried about giving incorrect informa-
tion or a false sense of hope. Furthermore, parents were concerned
Figure 1 Diagram to show the three phases of the research project.
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about their inability to rehearse or try out different ways of initiating
conversations with their children.
“It’s one of those things that you only get one chance [to do], you
don’t get to practice, unfortunately and it’s that practice that you
want... you can’t practice on your ﬁve year old” (Jane, Mother,
affected by Multiple Endocrine Neoplasia).
Children and young people reported feeling anxious, embarrassed
or nervous in attempting to initiate conversations about how they felt.
Simultaneously, parents felt that they did not have the emotional or
psychological input to support them. Due to these challenges all
participants (parents, children, and young people) reported that an
intervention speciﬁcally designed for families affected by or at risk
from IGCs was very necessary to facilitate family communication.
Theme 2: Designing the intervention. Parents, children, young people,
and GCs were asked to co-design an MFDG intervention that would
be acceptable to families affected by or at risk from IGCs and feasible
to implement in NHS practice. Participants’ discussions centred
around two sub-themes; intervention logistics and the inclusion and
exclusion criteria for attending families.
Intervention logistics. All participants saw value in the MFDG
concept presented and were keen for the intervention to be more
than a discussion group. Participants appreciated that engaging in
activities would encourage discussions and help family members’
understand each other’s perspectives and feelings aroused by the
impact of their IGC on family life. They also recognised the
importance of engaging in activities to facilitate bonding with their
own family members and also with the other MFDG families.
Children and young people were keen to engage with dramaturgical
or arts and crafts activities to keep them engaged and enthused but
also to help them communicate their ideas and feelings during
challenging discussions. The majority of parents saw the beneﬁts to
participating in activities for their children, but some parents thought
Table 1 Participants per research phase
Research
activity Family/GCs Inherited genetic condition Participants
Phase 1 Focus group A 1 Huntington’s disease (HD) Mother unaffected, son (aged 17) unaffected
2 Polycystic kidney disease (PKD) Mother affected, son (aged 11) affected by PKD
3 Prader Willi syndrome (PWS) Father unaffected by PWS, daughter (aged 9) unaffected by PWS
4 Huntington’s disease (HD) Mother unaffected by HD, father affected by HD, son (aged 14) at risk of HD, son
(aged 11) at risk of HD
5 Huntington’s disease (HD) Mother unaffected, Son (aged 18) at risk of HD, Daughter (aged 12) at risk of HD
6 Huntington’s disease (HD) Aunt/Carer, unaffected by HD, son (aged 18) at risk of HD, daughter (aged 11) at
risk of HD
7 Polycystic kidney disease (PKD) Father, affected by PKD, mother, not affected by PKD, son (aged 7), at risk of PKD
GCs N/A 7 genetic counsellors from genetics departments across the United Kingdom
Focus group B 2 Polycystic kidney disease (PKD)) Mother affected, son (aged 11) affected by PKD
4 Huntington’s disease (HD) Mother unaffected by HD, father affected by HD, son (aged 14) at risk of HD, son
(aged 11) at risk of HD
5 Huntington’s disease (HD) Mother unaffected, son (aged 18) at risk of HD, daughter (aged 12) at risk of HD
6 Huntington’s disease (HD) Aunt/Carer, unaffected by HD, son (aged 18) at risk of HD, daughter (aged 11) at
risk of HD
7 Polycystic kidney disease (PKD) Father, affected by PKD, mother, not affected by PKD, son (aged 7), at risk of PKD
GCs N/A 7 genetic counsellors from genetics departments across the United Kingdom
Focus group C 8 Polycystic kidney disease (PKD) Mother, affected by PKD
9 Multiple endocrine neoplasia (MEN) Mother, affected by MEN
10 Huntington’s disease (HD) Father, affected by HD
11 Vascular Ehlers-Danlos syndrome (EDS) Father, unaffected by V-EDS
GCs N/A 2 Genetic counsellors from London
Phase 2 Mock MFDG 2 Polycystic kidney disease (PKD) Mother affected, son (aged 11) affected by PKD
3 Prader Willi syndrome (PWS) Father unaffected by PWS
6 Huntington’s disease (HD) Aunt/Carer, unaffected by HD, son (aged 18) at risk of HD, Daughter (aged 11) at
risk of HD
7 Polycystic kidney disease (PKD) Father, affected by PKD, mother, not affected by PKD, son (aged 7), at risk of PKD
10 Huntington’s disease (HD) Father, affected by HD, grand-mother, not affected by HD
11 Vascular Ehlers-Danlos syndrome (V-EDS) Mother, unaffected by V-EDS, grandmother, unaffected by V-EDS
Phase 3 Pilot MFDG 3 Prader Willi syndrome (PWS) Father unaffected by PWS, mother unaffected by PWS, Son (aged 10) affected by PWS,
Daughter (aged 9) unaffected by PWS
12 Ehlers-Danlos syndrome (EDS) Mother affected by EDS, daughter (aged 11) at risk of EDS
13 Von Hipple Lindau disease (VHL) Mother affected by VHL, daughter, unaffected by VHL
14 Familial adenomatous polyposis (FAP) Grandmother, unaffected by FAP, granddaughter (aged 16) affected by FAP
15 Familial adenomatous polyposis (FAP) Mother, unaffected by FAP, stepfather, unaffected by FAP, son (aged 15), affected by FAP
16 Ehlers-Danlos syndrome (EDS) Mother, affected by EDS, daughter, at risk from EDS, daughter, at risk from EDS,
grandmother, unaffected by EDS, grandfather, affected by EDS
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that such participation could be embarrassing or uncomfortable for
adults.
John: “I think doing exercises...would be good for the children maybe...
but I think that it would put some adults off”
Sarah: “Yes, we have enough of those team building meetings at
work...I don’t want this to be another” (John, father of boy affected
by Prader Willi Syndrome; Sarah, Carer for family members
affected by and at risk of Huntington’s Disease).
Participants discussed possible venues to host the intervention.
All participants (parents, young people, and children) were
adamant that hospitals or medical facilities should not be used
because they conjure up memories. Participants preferred a neutral
building that was welcoming, comfortable, and quiet. Young people
wanted a venue that contained ﬂexible spaces to move about in as it
would prevent them from feeling pressured into participating in
activities. Young people also expressed the need for break-out areas
where they could talk to health professionals, other parents, or
peers in private.
“[It may] be helpful to have breakout areas...so if you think...I don’t
want to talk about these topics, but actually I’ve got this burning
question you can go to another area” (Jessica, young person at risk of
Huntington’s Disease).
Break-out areas were regarded as important by spouses and carers
who talked about wanting to be able to engage in group discussions
with peers who shared similar experiences, in the absence of their
affected or at risk partner, so that they did not have to worry about
saying something that would offend or upset them. Parents also saw
value in their children talking and sharing experiences with their peers.
“I can see a huge value with my child... being able to have a
conversation with her age group... I think peer aged appropriate
conversations would be very powerful because it is difﬁcult for us,
I mean who knows how to talk to an eight year old? Eight-year olds
like talking to other eight-year olds” (Jacob, Father of children at risk
from Polycystic Kidney Disease).
Appropriate timing of the intervention was thought to be at
weekends because evenings were tricky due to extra-curricular
activities. Also families did not want to talk to their employers or
their children’s school to request time out to attend the MFDG due to
fear of stigmatisation. Saturday afternoons with lunch were therefore
preferred. The MFDG should be no longer than half a day in length
and over several sessions, with parents, young people, and children
agreeing that they may become tired, both physically and emotionally
by the discussions and activities, causing difﬁculties concentrating if
the MFDG was longer than half a day.
“The idea of having a day which was 4–6 h long is way too long in my
opinion, you’ll have children getting exceptionally bored” (Jack, young
person at risk from Huntington’s Disease).
Considering the frequency of sessions, participants felt that because
discussions could be emotionally intensive, they did not want the
sessions to be too close together. They wanted time to think, reﬂect,
and perhaps implement some of the techniques. Conversely, they did
not want the sessions to be too far apart because they would be unable
to establish a rapport or friendships with the other families or lose
interest or momentum in attending. Participants however were unable
to come to an agreement about how many, the frequency and
duration of the MFDG sessions. Parents did agree that intermediate
support from their peer families would be valuable in implementing
what had been discussed and shared in the MFDG rather than waiting
for the next session.
Inclusion and exclusion criteria for attending families: Participants
discussed which families and/or family members would be eligible to
attend the intervention. Discussions centred on families’ IGC, how
much communication had already taken place within families and
how soon after diagnosis families should attend the MFDG.
In exploring what IGCs should be included, participants,
especially parents, initially felt that the MFDG should comprise
families affected by or at risk from the same IGC. Participants
initially advocated homogeneous MFDGs because they wanted to be
able to share experiences with families whom they perceived to be
in a similar situation and gain in-depth information about genetic
inheritance patterns and risks. Furthermore, parents felt that an
MFDG comprising different IGCs would confuse and upset their
children.
“I think...it’s quite difﬁcult...when people [don’t] understand what
other people [have got]...it’s really hard to relate to what [their]
problems and needs [are] compared to what...your family needs”
(Sarah, Carer for family members affected by and at risk of
Huntington’s Disease).
However, as discussions ensued, families’ opinions about group
composition evolved and participants thought that heterogeneous
MFDG’s would help them to learn about different viewpoints and
experiences, which might be even more beneﬁcial. They began to see
communication challenges as similar regardless of the IGC and
concluded that sometimes the differences could actually provide new
perspectives and they would not be so focused on the disease but on
the effects on the family.
“I don’t think it matters. I think the issue is that you’ve got a genetic
disease that can be passed onto the children” (Sarah, the above Carer
in previous quotation).
Participants discussed how much communication was necessary
before families could attend the MFDG. Parents who had not spoken
to their children felt that no prior communication was required to be
able to attend the MFDG as long as their children were absent. They
believed there would be value in meeting other parents who had
already initiated conversations, and felt that they could learn from that
experience, helping them to gain conﬁdence in initiating conversations
with their own children. For the majority of participants however, they
believed that a conversation needed to occur before attending the
MFDG. The quality and quantity of this disclosure was however not
speciﬁed with parents feeling that mixing parents at different stages of
the disclosure process could be helpful in terms of receiving and
sharing ideas. Some parents expressed concern that they often
witnessed others who took polarised views in support groups about
when and how children should be told about a speciﬁc IGC and this
could cause friction. Parents from focus groups A, B, and C suggested
those parents who had not talked to their children at all might need a
different intervention.
Participants discussed what might be the appropriate time for
families to attend the MFDG following diagnosis. The majority of
parents agreed that the timing would depend on the individual’s ability
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to cope with the information and whether they had already engaged in
a conversation with their children.
Philip...An experience on the day of diagnosis. It happened [around
mid-afternoon] and by [early evening] we were driving around
immediate family members... Some family members instantly ﬁlled
up, ‘Right, what is it? How can we help?’...My brother, didn’t show
any emotion...It was six months later, [when] it hit him...
Alison: In some ways there wouldn’t be any rules about whether it was
immediate after diagnosis, it could be ten years or ﬁfteen years down
the line. There wouldn’t be a rule about when you could access it...
people come to terms with it at different points in time...
Jane: hmmm, I don’t believe it really hit me until...about six weeks
ago...I’m a very up, positive, happy person and I was just ﬂat...and
that was ﬁve years post-diagnosis...
(Philip, Father of a Daughter affected by Vascular Ehlers Danlos
Syndrome, focus group facilitator (AM) and Jane, Mother affected
by Multiple Endocrine Neoplasia).
Finally, family members wanted to decide who attended the MFDG
and whether they should invite extended family members or friends.
Children and young people speciﬁcally wanted their friends to attend
because they would be more comfortable talking to their friends than
to their parents or siblings. Despite this, the majority of children and
young people stated that being in an MFDG with their siblings was not
a concern with the exception of one young person who suggested that
he would be more comfortable and relaxed in talking to peers if his
younger sibling was not present.
“I guess it would come down to age, for example Phillipa and I,
Phillipa would want me there if there were new people, more than
I would want her there with me because I am a lot older than her...
I maybe more comfortable talking without her” (Jack, young person
at risk of Huntington’s Disease).
Concluding the focus groups, participants discussed the perceived
beneﬁts for families from attending MFDGs. For many participants
gaining conﬁdence and engaging in open communication with family
members was regarded as the main beneﬁts, by giving them the tools
and methods to communicate more effectively with each other and
build their conﬁdence in posing and/or answering questions effectively
(see Figure 2).
Participants also perceived that MFDG attendance would lead to a
happier home life with fewer arguments, more conversations and
more family outings (Figure 3). Beneﬁts to the health-care system were
also acknowledged, with one young person stating that if the
intervention was successful, it would reduce service use in other areas
and therefore be cost effective for the health service.
“You’ve also to be thinking from a health care point of view, if you get
something like this right, you could be saving money and time further
down the line and I think that’s what the bigwigs need to understand.
If you get something that saves the emotional side, half the time you’ll
save money later...it causes fewer problems if you just help someone
talk” (Jack, young person at risk from Huntington’s Disease).
Logistical challenges such as travel costs and/or child care costs were
also seen as a barrier for some families’ participation. The most
prevalent barrier to attending the MFDG however were parents’
anxieties surrounding children’s exposure to other IGCs. Parents
perceived that being exposed to families with children affected by life-
limiting conditions would upset their children.
“If I went to the ﬁrst group and I found out that there were families
there with a terminal illness, I would be less inclined to go to another
one because I wouldn’t want to expose [my child] to those situations”
(John, Father of a Son affected by Prader Willi Syndrome).
Phase 2: Development of intervention and training
The research team and family therapists used the focus group ﬁndings
to adapt MFDGs for use with families affected or at risk from IGCs
and three GCs were trained to deliver the intervention. Three multi-
perspective interviews conducted before, during, and after the training
captured the GCs shifting perspectives about the MFDG and their
experiences of the training.39
In the ﬁrst interview, the GCs were enthused about being trained in
delivering the MFDG. They perceived that the training would improve
their genetic counselling skills enabling them to counsel multiple
families together and build their conﬁdence in supporting families to
communicate the risks associated with the IGC. However, they were
also anxious because the training was very different from their current
Figure 2 A picture showing a family before and after attending the MFDG
intervention. In the before image the child is sad and confused asking
their parent “why can’t you tell me?” In the after picture the child is
happier because he understands what is happening in his family because
his parents have been ‘able to tell his son a bit more about the genetic
disease’.
Figure 3 A picture showing the child’s family before and after the
intervention. In the before picture, the child has written by an image of his
home ‘we are so sad’ and in the after picture the child has written ‘we are
so happy’.
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genetic counselling training and therefore would lead to a new and
unfamiliar way of practicing genetic counselling in the future.
Glenn: Why did you volunteer?
Katie (GC1): I think it seemed like a new skill and... It hasn’t been
done before....
Anna (GC2): Similar for me, [the research] sounded quite exciting,
something completely new.... I also have a lot of concern about families
communicating genetic results... so I want to know how to do it better
and I thought I could learn a lot from this study not only skill wise but
in terms of very speciﬁc genetic problems....
Glenn: Have you taken part in any similar training previously?
Anna (GC2): Nothing like this...
Rita (GC3): No I mean... it’s part of our training as genetic
counsellors to have some level of training in terms of communicating
with families but....
Katie (GC1): ...not with family groups...
Rita (GC3): ...and although our title is genetic counselling and we all
have genetic counselling skills, a lot of what we do is completely
different to therapeutic counselling....
(Multi-perspective interview 1 with GCs)
Following the commencement of training, the GCs participated in a
second multi-perspective interview. At this time, all GCs were
apprehensive about implementing the MFDG into practice. They
were concerned about their ability and competence to facilitate the
discussion groups and queried the recruitment of appropriate families
to the intervention. There were also practical issues surrounding when
these MFDGs should be conducted to accommodate the needs of
families and also to assimilate with their department’s current practice
and organisational culture, as well as within wider NHS’ ﬁnancial and
human resources:
Glenn: In terms of them embedding it in routine practice in the
service what do you think might be some of the obstacles to that,
if any?
Katie (GC1): The obvious one that springs to mind is our lack of
experience in running something like this, I know we get training for it
but we will be under supervision when we do all of this and then it
ﬁnishes and then we’re kind of on our own and... that’s one of my
fears...
Anna (GC2): I think if we were to run our own multi family groups...
it’s so hard to get families with children... These are children who are
in school... I don’t really understand how you get all these families and
professionals all to be together at the same time...it seems like a huge
challenge.
Rita (GC3): Yet another barrier to this, a negative is just literally the
environment that we’re working in now. I mean we’re all absolutely
stretched, we’re being asked to see more and more patients in less and
less time and although we’re all.... highly motivated, even just ﬁnding
the time to do this kind of training is difﬁcult and so I think that poses
a huge challenge in terms of future care. (Multi-perspective interview
2 with GCs).
Due to the GC’ anxieties, apprehensions, and concerns, training
took longer than anticipated. However, it was important that the GC
felt conﬁdent in their ability to facilitate the groups before moving to
phase 3. Conﬁdence in the MFDG and their facilitation skills were
enhanced through the observation of MFDG’s with families in a
service treating eating disorders, conducting MFDG activities with
peers and co-facilitating a mock MFDG with families who had
participated in phase 1. The family therapist (SH) debriefed the GCs
following these activities to support their education and learning.
Phase 3: Piloting the intervention
With the GCs conﬁdent in their ability to co-facilitate a MFDG, the
intervention was conducted over one weekend in November 2014 and
was attended by six families affected by or at risk from a variety of
IGCs. The families comprised six parents and one step-parent, three
grandparents, ﬁve young people (13–18 years), and three children
(7–11 years) (see Table 1). Families participated in 12 h of scheduled
MFDG activities over 2 days. The pilot intervention provided under-
standing of how the intervention could be reﬁned for a future
randomised control trial (RCT), to test its acceptability to families
and the feasibility of delivering a deﬁnitive RCT with families affected.
Initially participants, especially young people and children, found
the idea of sharing personal thoughts, feelings, and experiences with
other families daunting or intimidating. However, through their
interactions with other families and sharing their experiences with
peers, who were able to understand and relate to what it is like living
with an IGC, they thought the MFDG was hugely beneﬁcial. The
intervention therefore was not only considered acceptable but invalu-
able to their emotional well-being and their family’s functioning.
“It was a very good experience as Laura [grand-daughter] and myself
were able to talk to other people in the group about our condition and
they did not judge us and no blame was attached... To actually talk to
people who knew what it was like to have genetic problems... we knew
that we were not alone. So many people who do not have a genetic
condition just do not understand how it feels and I have been told
many times to “just get on with it” and “it’s just life”, they have no
idea what it is like or to lose a child through these conditions. The
group discussions [have] been very welcome... in my life as I was able
to talk about things I have not disclosed to anyone else. It felt a lot had
been taken off my shoulders and I can go forward with a much
positive view on life. This is a brilliant way of helping people with
genetic conditions and I would deﬁnitely attend further sessions if these
were available. I would highly recommend genetic group discussions
for families with these conditions.”
(Hollie, Grand-mother affected by Familial Adenomatous
Polyposis).
Participants also recognised the beneﬁt of the MFDG activities and
exercises in facilitating communication and enabling them to under-
stand issues and concerns from each other’s perspectives as well as
gaining advice from other families in how to manage challenges faced:
“[The exercises] helped to bring the family together. They helped me to
understand what [my] children are going through from their point of
view and how to solve the daily hurdles” (Jessica, Mother of a son
affected by Familial Adenomatous Polyposis).
Having families with different IGCs was thought very beneﬁcial by
the participants because they heard and saw different ways of coping
and talking about it. During the sessions parents reported how surprised
they were that most of the issues they shared were similar, and usually
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focused on ﬁnding different ways of coping with the socio-psychological
effects of the IGC on the family, rather than the IGC itself.
Participants recognised that the facilitator’s role was important to
the execution of the MFDG and to their outcomes. The majority of
participants attending the pilot MFDG reported that the sessions had
been facilitated well by the family therapist, research team and three
GCs, stating that all the facilitators had been approachable and had the
ability to manage group dynamics. This allowed participants to feel
comfortable in sharing information with other families and manage-
ment of potentially distressing situations. Participants thought it was
important that the facilitators had both a good understanding of IGCs
and an understanding of the wider social and emotional context.
Families’ reported that they would recommend the intervention to
others and would also want to attend future discussion groups as a
‘graduate family’ to encourage other families to participate.
Following the MFDG, all three GCs reported that they were excited,
motivated, and encouraged by their positive experiences of
co-facilitating the MFDG and in witnessing the beneﬁt to families.
In the ﬁnal multi-perspective interview, the GCs expressed their
fervour for the MFDG and their eagerness to be involved in future
research to facilitate the implementation of the MFDG into practice.
They were also reassured that GC could be trained to deliver the
intervention to families affected or at risk from IGCs.
Katie (GC 1): I think we all weren't sure that it was really going to
work, whether it would be beneﬁcial to the families. I think by the end
of [the MFDG] we all agreed that they did get something out of it and
we got something out of it as well and it felt a lot more smoother,
for whatever reason, and it just seemed like it ﬂowed better and
we were much better and more conﬁdent in what we were doing.
(Multi-perspective interview 3 with GCs).
DISCUSSION
The impact of genetic risk information on individuals and their
families should not be underestimated, and ﬁnding ways of helping
people to manage that information and to prevent it from disrupting
their family functioning is essential as genetic testing becomes more
routine. Simply giving people information is not sufﬁcient, especially
when many cannot take actions to alter the outcomes of the disease. It
is imperative therefore to help families integrate the IGC into their
lives while maintaining a cohesive and resilient family network to
ensure they maintain a good quality of life, where the family’s identity
is not eroded or eclipsed by the IGC, as can so often happen.
Our previous work and that of others3,5–7,9,14,40 has shown the
necessity of supporting families’, to assist their adaptation to and
coping with the IGC. This present research has now signiﬁcantly
progressed towards meeting this need by co-designing an intervention
to promote and support family communication through adapting
MFDGs co-facilitated by family therapists and GCs. With training,
GCs were able to deliver such an intervention and deal with the
complexity of socio-psychological issues that emerged during the
sessions, demonstrating the acceptability of the MFDG to these health
professionals. The families receiving the intervention also found it very
beneﬁcial and most have offered to act as future ambassadors and
advocates to other families for future programmes, clearly demon-
strating acceptability to families.
MFDGs need to be delivered at weekends as families do not want to
talk to their employers or children’s schools because they fear being
stigmatised, an issue that was raised repeatedly during our MFDGs.
Families also wanted to avoid hospital settings and these factors should
be built into the design of future studies to test the effectiveness and
economic viability of delivering the MFDG as part of future service
provision. While there might be increased costs of delivering the
intervention at the outset, in the longer term there are likely to be
better outcomes for families and their individual members. Improved
social-psychological care will lead to signiﬁcantly reduced use of
mental health and primary care services, which many families
currently report they use as they struggle to cope.3,9,12
There were limitations to our work. The GCs required more
training and development than we had originally anticipated, which
we hypothesise is largely due to the limited training in family systems
therapy and the lack of experience in working with multiple families in
a single session. Further work is required to determine the future role
of GCs in supporting family communication about IGCs because there
is a risk in the future, with the advances on genomic medicine, for
example, the 100 000 genome project in the United Kingdom, there
may become a greater emphasises on genetic testing and this has to be
done in parallel with attention on facilitating families’ coping. The
MFDG provides a comprehensive way of doing this. Further many
families taking part reported never having the opportunity to receive
genetic counselling and therefore offering these types of multi-family
intervention may have an important role in facilitating these families’
understanding and coping with the IGC. The research may also be
limited by the sample of families participating, with families unwilling to
communicate genetic information, unlikely to participate in the research.
Parents in the focus groups had difﬁculty in differentiating between
the focus group they were in to design the intervention and the actual
intervention. Most parents and young people reported therapeutic
effects of simply taking part in the focus groups, despite the non-
therapeutic role of focus groups being emphasised at the meetings.
Parents’ views on how the MFDG should be delivered, that is, a series
of half day groups on a Saturday with lunch turned out to be
inappropriate when it came to recruitment for piloting the interven-
tion. Instead parents preferred one intensive weekend. On reﬂection,
focus group parents were mirroring the focus group design and this
requires consideration in designing future interventions because these
participants could not envisage the MFDG, and following the half day
mock session, all the participants wanted the day to go on longer.
Therefore, some elements of co-design emerged beyond the focus
groups.
CONCLUSION
We have worked with parents, children, young people, and health
professionals to co-design an MFDG intervention to facilitate better
communication about an IGC in families affected by or at risk from
an IGC, and demonstrated this to be acceptable and feasible. This is
the ﬁrst intervention of its kind for families affected by IGC. We are
now working on the further evaluation and testing of the effectiveness
and economic viability of the intervention before it is integrated into
genetic counselling practice.
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